Abstract
INFLUENCE OF SYMBIOTIC FUNGI ON ARTEMISIA ANNUA L.-A MEDICINAL PLANT

Monika Gupta*, Monika Arora and Ajit Varma

ABSTRACT

Importance: Artemisinin is a potent antimalarial natural compound, obtained from the aerial portion of the plant - Artemisia annua L. The demand for artemisinin is exponentially increasing due to enhanced incidence of drug resistant malaria. However, the low yield of this anti-malarial drug is a major constraint in the commercialization. Several methods have been used since long but have not been found attainable on large scale. Hence outsized farming of A. annua is the only solution for the production of Artemisinin. Observation: A significant increase in artemisinin, an active compound in plant, used as anti-malarial drug under combination therapies recommended by WHO for treating multidrug resistance in malaria, has been achieved on inoculation with Piriformospora indica (Serendipita indica) and Azotobacter chroococcum in combination. The quantity of artemisinin was significantly higher (2.4 fold higher) on dual inoculation as compared to control. Conclusion and Relevance: The greenhouse and field trials have led enhanced plant growth and artemisinin content. At moment it is not clear the mechanism by which the artemisinin content is increased. The understanding of the mechanism will promise to help further enhancement artemisinin content. Past few years, efforts have been made to co-culture plant with symbiotic mycorrhizal fungi and azotroph. Results indicated a positive impact.

Keywords: Artemisinin, P. indica, A. chroococcum, A. Annua.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: OCTOBER ISSUE PUBLISHED

    OCTOBER 2026 Issue has been successfully launched on 1 OCTOBER 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT